PersonDr. Chris Thompson

Chris Thompson

Professor at Harvard Medical School and Director of Interventional Gastroenterology at Massachusetts General Hospital. His research and clinical practice focus on digestive system diseases, metabolic health, and endoscopic surgery.

Timeline (last 90 days)

Sep 25

In Thompson's clinical endoscopic treatment practice, more than 85% of patients have already used GLP-1.

Unverified50%

Sep 25

Thompson developed ESG (Endoscopic Sleeve Gastroplasty) in 2012, which folds and reduces the stomach in size via oral access.

Unverified50%

All Facts (2)

Unverified

In Thompson's clinical endoscopic treatment practice, more than 85% of patients have already used GLP-1.

50%Unverified

Thompson developed ESG (Endoscopic Sleeve Gastroplasty) in 2012, which folds and reduces the stomach in size via oral access.

50%

Source Articles

Gut Health & Weight Loss: A Complete Scientific Guide from Fiber to GLP-1Sep 25